EP3819007
Skömmtunaráform fyrir and-BCMA miðla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.11.2019EP published:
10.7.2024EP application number:
19208417.6
EP translation filed:
23.9.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
10.11.2039Expiry date:
10.11.2026Next due date:
30.11.2026
Title in English:
DOSING REGIMEN FOR ANTI-BCMA AGENTSLanguage of the patent:
English
Timeline
Today
11.11.2019EP application
10.7.2024EP Publication
23.9.2024Translation submitted
15.10.2024Registration published
10.11.2026Expires
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477 München, DE
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Inventor
Name:
Stieglmaier, JuliaAddress:
81477 München, DE
Name:
Huber, BirgitAddress:
81477 München, DE
Name:
Minella, AlexanderAddress:
Thousand Oaks, CA 91320, US
Name:
Upreti, VijayAddress:
Thousand Oaks, CA 91320, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 39/00, A61K 39/395, C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 22.11.2024
Expires: 10.11.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.11.2025
Expires: 10.11.2026
Payer: Árnason Faktor ehf.